Slate Run Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SLATE RUN PHARMA, and what generic and branded alternatives to SLATE RUN PHARMA drugs are available?
SLATE RUN PHARMA has twenty-five approved drugs.
Summary for Slate Run Pharma
| US Patents: | 0 |
| Tradenames: | 23 |
| Ingredients: | 23 |
| NDAs: | 25 |
Drugs and US Patents for Slate Run Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Slate Run Pharma | LINCOMYCIN HYDROCHLORIDE | lincomycin hydrochloride | INJECTABLE;INJECTION | 216662-001 | Dec 21, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Slate Run Pharma | GANCICLOVIR SODIUM | ganciclovir sodium | INJECTABLE;INJECTION | 204204-001 | Nov 8, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Slate Run Pharma | DOXYCYCLINE HYCLATE | doxycycline hyclate | INJECTABLE;INJECTION | 217685-002 | Jun 21, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
